Abstract:Heterogeneity of neurodegenerative diseases, including Alzheimer’s disease (AD), has hampered precision diagnosis and prognosis. Machine learning methods are able to dissect neuroanatomical heterogeneity and enable identification of disease subtypes via their imaging signatures. We apply a novel semi‐supervised deep‐learning clustering method to derive dimensions of neurodegeneration, and investigate longitudinal paths in this dimensional system. Analyses used structural MRIs (from the Alzheimer’s Disease Neuroimaging Initiative and the Baltimore Longitudinal Study of Aging; total 2,832 participants; 8,146 scans) including controls and patients with Mild Cognitive Impairment (MCI) and AD. Smile‐GAN identified 4 neurodegenerative patterns/axes (Figure 1): P1, normal anatomy; P2, mild/diffuse atrophy; P3, focal medial temporal atrophy; P4, advanced neurodegeneration. Further application to longitudinal data revealed two distinct progression pathways: P1→P2→P4 and P1→P3→P4. Clinically, P2 participants showed worse performance in executive function than P3 participants (median ADNI‐EF= ‐0.29 vs. ‐0.1, with p=0.038) but had better memory (ADNI‐MEM= ‐0.13 vs. ‐0.39, with p=0.003) (Figure 2). Progression to P4 occurred more rapidly from P3 than P2, with median survival time to progression of 4.5 years and 3.2 years for P2 and P3 MCI/Dementia participants, respectively. Baseline expression of these patterns predicted the pathway and rate of future neurodegeneration, with high accuracy for determining whether P1 participants would progress and whether they would progress to P2 or P3 (Cox‐proportional‐hazard model average concordance index (CI) on the validation set of 0.8±0.02). Pattern expression offered better performance (CI=0.72±0.02) in predicting clinical conversion from MCI to Dementia compared to amyloid/tau (CI=0.69±0.02), with all three together showing modest improvement over pattern performance (CI=0.76±0.02). A composite risk score comprised of pattern probabilities, Abeta, pTau, presence of APOE E4, and ADAS‐cog score was able to predict survival time with an average concordance index, 0.78±0.02 on randomly split validation sets. (Figure 3). Four reproducible volumetric patterns, and 2 major longitudinal pathways were revealed using deep learning, which can be determined on an individual patient basis and has implications for rate of future decline. These pattern‐based biomarkers can enrich the N‐dimension of the A/T/N framework which may inform on clinical trial enrollment and monitoring outcomes in a more personalized manner.

Visualizing Alzheimer's Disease Progression in Low Dimensional Manifolds.

TRACKING ALZHEIMER’S DISEASE PROGRESSION BY NON-LINEAR DIMENSION REDUCTION OF BRAIN MRI FEATURES

Longitudinal Volumetric Study for the Progression of Alzheimer's Disease from Structural MRI

A unique color-coded visualization system with multimodal information fusion and deep learning in a longitudinal study of Alzheimer's disease

Deep Geometric Learning with Monotonicity Constraints for Alzheimer's Disease Progression

MAPPING ALZHEIMER'S DISEASE PSEUDO-PROGRESSION WITH MULTIMODAL BIOMARKER TRAJECTORY EMBEDDINGS

Disentangling brain heterogeneity via semi‐supervised deep‐learning and MRI: Application to dimensional representations of Alzheimer’s disease

Classification and Visualization of Alzheimer’s Disease using Volumetric Convolutional Neural Network and Transfer Learning

Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization

An Efficient Approach For Differentiating Alzheimer'S Disease From Normal Elderly Based On Multicenter Mri Using Gray-Level Invariant Features

Prediction of Alzheimer's Progression based on Multimodal Deep-Learning-based Fusion and Visual Explainability of Time-Series Data

Group Guided Fused Laplacian Sparse Group Lasso for Modeling Alzheimer's Disease Progression.

High Dimensional Classification for Spatially Dependent Data with Application to Neuroimaging

Mapping the multidimensional geometric landscape of graded phenotypic variation and progression in neurodegenerative syndromes

Visualizing Convolutional Networks for MRI-based Diagnosis of Alzheimer's Disease

High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction.

From Brain Imaging to Graph Analysis: a Study on ADNI's Patient Cohort.

Dynamic Survival Prediction Using Sparse Longitudinal Images via Multi-Dimensional Functional Principal Component Analysis

Attention-guided 3D CNN With Lesion Feature Selection for Early Alzheimer's Disease Prediction Using Longitudinal sMRI

High-Dimensional Smoothing Splines and Application in Alzheimer's Disease Prediction Using Magnetic Resonance Imaging

Nonlinearity-aware Based Dimensionality Reduction and Over-Sampling for AD/MCI Classification from MRI Measures.